Fields of Focus
Our unwavering focus on crafting curative medicines, personalized therapies, novel therapeutics, and fostering new scientific breakthroughs distinguishes us from other life science companies.
Our primary areas of interest encompass severe infectious diseases, notably HIV I and II, AIDS, HSV I and II, owing to their complex and elusive nature. Nevertheless, our commitment extends to allocating resources to delve into other crucial areas, including neurological diseases, genetic conditions, and rare diseases.
Our Mission
We aim to collaborate with companies possessing proprietary technology within the biotechnology sector, particularly in the fields of genomic engineering and sequencing. These partnerships are integral to advancing our research and development endeavors in infectious disease diagnostics, as well as cell and gene therapies.
These groundbreaking scientific advancements and diverse innovations will provide us with a deeper comprehension of the potential for eventual eradication of the aforementioned illnesses. Our mission is to pioneer drugs that can effectively rectify these issues by uncovering novel cellular mechanisms, signaling pathways, and molecules essential for gene editing.
These scientific breakthroughs and varying innovations will give us a better understanding of how the above-mentioned ailments can eventually be eradicated.
Meet Our Founder, Jason Clark
Hello, we are delighted to have you here. We eagerly anticipate embarking on new journeys together, one step at a time.
Learn About Our Founder
A native of Baltimore, MD - Jason received his B.S. in Biology from Salisbury University in 2018. After completing his undergraduate degree, he utilized his acumen and passion for research and science as a researcher at the Naval Medical Research Center (also known as Walter Reed Army Institute of Research) in the Neurotrauma branch under the United States Department of Defense.
He then relocated to Atlanta, GA where he worked in Clinical Research/Clinical Trials at the site level in Investigational Products (drug development). Once he excelled at the site level, he yearned for a more well-rounded knowledge base. This resulted in shifting to the Clinical Research Organization (CRO) level to work in the monitoring & managing of medical device & biotech. clinical trials.
This heavy research background allowed him to understand the 3 levels that clinical trials require to successfully study the efficacy of a drug or device (Sponsor, CRO, & Site.) By creating a company considered to be a sponsor, he has a firm grasp on the stages of Drug Development & phases of a clinical trial required to safely study for human benefit.
